Abstract
We conducted a prospective study in 54 patients with a median age of 48 years (range 23–73) to determine the prevalence and dynamics of optic nerve remyelination after methanol-induced optic neuropathy. Methanol was measured by a gas chromatographic method with flame ionization detection. Formate was measured enzymatically. Measurement of full-field visual evoked potential with monocular checkerboard pattern-reversal stimulation was performed 3–8 and 24–28 months after discharge. The latency of the positive peak (P1) was used for the analysis of remyelination dynamics. Twenty-seven patients had abnormal P1 latencies. Mean P1 latency for right eyes (REs) was 115.3 ± 2.1 ms and for left eyes (LEs) was 117.4 ± 3.2 ms. The group with abnormal latency had lower arterial pH (p = 0.017), higher anion gap (p = 0.013), methanol (p = 0.027), base deficit (p = 0.033), and lactate (p = 0.048). At the second examination, shortening of P1 latencies was registered (REs/LEs 98.3 ± 2.4/102.7 ± 4.5 ms; p < 0.001). The dynamics of latency shortening for REs/LEs were 17 ± 1.3/15.1 ± 3.1 ms, with insignificant inter-eye difference (p = 0.271). The dynamics of remyelination correlated with serum methanol (r = −0.588; p < 0.001), arterial pH (r = 0.339; p = 0.040), and concentration of carbohydrate-deficient transferrin (r = −0.411; p = 0.011). Remyelination occurred in cases of mild or moderate damage of myelin sheaths; no improvement of conduction was found in severe cases. The dynamics of remyelination correlated with the degree of acidosis and severity of poisoning. Chronic alcohol abuse had a negative effect on remyelination dynamics.
Graphical abstract
Similar content being viewed by others
References
Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D (2005) J Intern Med 258:181
Paasma R, Hovda KE, Tikkerberi A, Jacobsen D (2007) Clin Toxicol 45:152
Kumar SS, Seerala Boopathy K, Bhaskar ME (2003) J Assoc Physicians India 51:425
Ahmad K (2000) The Lancet 356:1911
Zakharov S, Pelclova D, Urban P, Navratil T, Diblik P, Kuthan P, Hubacek JA, Miovsky M, Klempir J, Vaneckova M, Seidl Z, Pilin A, Fenclova Z, Petrik V, Kotikova K, Nurieva O, Ridzon P, Hovda KE (2014) Clin Toxicol 52:1013
Zhang G, Grews K, Wiseman H, Bates N, Hovda KE, Archer JR, Dargan PJ (2012) Application to Include Fomepizole on the WHO Model List of Essential Medicines. http://www.who.int/selection_medicines/committees/expert/19/applications/Fomepizole_4_2_AC_Ad.pdf. Accessed 17 July 2015
Roberts DM, Yates C, Megarbane B, Winchester JF, Maclaren R, Gosselin S, Nolin TD, Lavergne V, Hoffman RS, Ghannoum M, Treatments E (2015) Crit Care Med 43:461
Liesivuori J, Savolainen H (1991) Pharmacol Toxicol 69:157
Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) J Toxicol Clin Toxicol 40:415
Osterloh JD, Pond SM, Grady S, Becker CE (1986) Ann Intern Med 104:200
Zakharov S, Kurcova I, Navratil T, Salek T, Komarc M, Pelclova D (2015) Basic Clin Pharmacol Toxicol 116:445
Vaneckova M, Zakharov S, Klempir J, Ruzicka E, Bezdicek O, Liskova I, Diblik P, Miovsky M, Hubacek JA, Urban P, Ridzon P, Pelclova D, Burgetova A, Masek M, Seidl Z (2014) Cesk Slov Neurol N 77:235
Akhtari K, Hassanzadeh K, Fakhraei B, Fakhraei N, Hassanzadeh H, Akhtari G, Zarei S, Hassanzadeh K (2015) Monatsh Chem 146:601
Megarbane B, Borron SW, Baud FJ (2005) Intensive Care Med 31:189
Zakharov S, Navratil T, Pelclova D (2014) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:641
Zakharov S, Pelclova D, Navratil T, Belacek J, Komarc M, Eddleston M, Hovda KE (2015) Clin Toxicol 53:797
Sharpe JA, Hostovsky M, Bilbao JM, Rewcastle NB (1982) Neurology 32:1093
Carelli V, Ross-Cisneros FN, Sadun AA (2004) Prog Retin Eye Res 23:53
Paasma R, Hovda KE, Jacobsen D (2009) BMC Clin Pharmacol 9:5
Zakharov S, Pelclova D, Diblik P, Urban P, Kuthan P, Nurieva O, Kotikova K, Navrátil T, Komarc M, Seidl Z, Vaneckova M, Hubacek JA, Bezdicek O, Klempir J, Ridzon P, Ruzicka E, Miovsky M, Janikova B, Hovda KE (2015) Clin Toxicol. doi:10.3109/15563650.2015.1086488
Paasma R, Hovda KE, Hassanian-Moghaddam H, Brahmi N, Afshari R, Sandvik L, Jacobsen D (2012) Clin Toxicol 50:823
Zakharov S, Navratil T, Pelclova D (2015) Monatsh Chem 146:787
Zakharov S, Navratil T, Salek T, Kurcova I, Pelclova D (2015) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. doi:10.5507/bp.2015.008
Jones SJ, Brusa A (2003) J Neurol Sci 206:193
Brusa A, Jones SJ, Kapoor R, Miller DH, Plant GT (1999) J Neurol 246:776
Brusa A, Jones SJ, Plant GT (2001) Brain 124:468
Scrimgeour EM, Dethlefs RF, Kevau I (1982) Med J Aust 2:481
Sharpe JA, Hostovsky M, Bilbao JM, Rewcastle NB (1982) Neurology 32:1093
Hantson P, de Tourtchaninoff M, Simoens G, Mahieu P, Boschi A, Beguin C, Guerit JM (1999) Crit Care Med 27:2707
Martin M, Hiltner TD, Wood JC, Fraser SE, Jacobs RE, Readhead C (2006) J Neurosci Res 84:1716
Klistorner A, Chaganti J, Garrick R, Moffat K, Yiannikas C (2011) Neuroimage 56:21
Smith I, Kumar P, Molloy S, Rhodes A, Newman PJ, Grounds RM, Bennett ED (2001) Intensive Care Med 27:74
Sanaei-Zadeh H, Esfeh SK, Zamani N, Jamshidi F, Shadnia S (2011) J Med Toxicol 7:189
Misra UK, Kalita J, Das A (2003) Electromyogr Clin Neurophysiol 43:57
Fei GQ, Zhong C, Jin L, Wang J, Zhang Y, Zheng X, Zhang Y, Hong Z (2008) Am J Neuroradiol 29:164
Yeh WY, Lian LM, Chang A, Cheng CK (2013) J Formos Med Assoc 112:165
Fernandez M, Giuliani A, Pirondi S, D’Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L (2004) Proc Natl Acad Sci USA 101:16363
Veselinovic D, Jovanovic M (2005) Acta Fac Med NAISS 22:145
Grzybowski A, Zulsdorff M, Wilhelm H, Tonagel F (2015) Acta Ophthalmol (Copenh) 93:402
Love S (2006) J Clin Pathol 59:1151
Stibler H (1991) Clin Chem 37:2029
Zakharov S, Pelclova D, Navratil T, Belacek J, Kurcova I, Komzak O, Salek T, Latta J, Turek R, Bocek R, Kucera C, Hubacek JA, Fenclova Z, Petrik V, Cermak M, Hovda KE (2014) Kidney Int 86:199
Zakharov S, Nurieva O, Navratil T, Diblik P, Kuthan P, Pelclova D (2014) J Appl Biomed 12:309
Mehraban K, Gmeiner G, Urban E, Gärtner P, Eppacher S, Noe CR (2014) Monatsh Chem 145:1631
Laila A (2013) Monatsh Chem 144:307
Aabakken L, Johansen KS, Rydningen EB, Bredesen JE, Ovrebo S, Jacobsen D (1994) Hum Exp Toxicol 13:131
Collins DW, Black JL, Mastaglia FL (1978) J Neurol Sci 36:83
Acknowledgments
Supported with the Project of the Ministry of Health of the Czech Republic 9/15/NAP, the Projects of the Charles University in Prague PRVOUK—P25/1LF/2, P26/1LF/2, and P28/1LF/6, and EU Project “Material—technical Research Base for the Diagnostics and Treatment of Environmentally caused and Oncological Disorders and their Risks, in the General University Hospital in Prague” (Reg. No. CZ.2.16/3.1.00/24.12).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nurieva, O., Kotikova, K., Urban, P. et al. Prevalence, dynamics, and biochemical predictors of optic nerve remyelination after methanol-induced acute optic neuropathy: a 2-year prospective study in 54 patients. Monatsh Chem 147, 239–249 (2016). https://doi.org/10.1007/s00706-015-1580-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-015-1580-y